HEADER HYDROLASE/HYDROLASE INHIBITOR 17-FEB-98 1A5I TITLE CATALYTIC DOMAIN OF VAMPIRE BAT (DESMODUS ROTUNDUS) SALIVA PLASMINOGEN TITLE 2 ACTIVATOR IN COMPLEX WITH EGR-CMK (GLU-GLY-ARG CHLOROMETHYL KETONE) COMPND MOL_ID: 1; COMPND 2 MOLECULE: PLASMINOGEN ACTIVATOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 213-477; COMPND 5 EC: 3.4.21.68; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: DESMODUS ROTUNDUS; SOURCE 3 ORGANISM_COMMON: COMMON VAMPIRE BAT; SOURCE 4 ORGANISM_TAXID: 9430; SOURCE 5 ORGAN: SALIVARY GLANDS; SOURCE 6 EXPRESSION_SYSTEM: MESOCRICETUS AURATUS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: GOLDEN HAMSTER; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 10036; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: BHK KEYWDS SERINE PROTEASE, FIBRINOLYTIC ENZYMES, PLASMINOGEN ACTIVATORS, KEYWDS 2 HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.RENATUS,M.T.STUBBS,W.BODE REVDAT 5 30-OCT-24 1A5I 1 REMARK REVDAT 4 02-AUG-23 1A5I 1 REMARK LINK REVDAT 3 13-JUL-11 1A5I 1 VERSN REVDAT 2 24-FEB-09 1A5I 1 VERSN REVDAT 1 23-MAR-99 1A5I 0 JRNL AUTH M.RENATUS,M.T.STUBBS,R.HUBER,P.BRINGMANN,P.DONNER, JRNL AUTH 2 W.D.SCHLEUNING,W.BODE JRNL TITL CATALYTIC DOMAIN STRUCTURE OF VAMPIRE BAT PLASMINOGEN JRNL TITL 2 ACTIVATOR: A MOLECULAR PARADIGM FOR PROTEOLYSIS WITHOUT JRNL TITL 3 ACTIVATION CLEAVAGE. JRNL REF BIOCHEMISTRY V. 36 13483 1997 JRNL REFN ISSN 0006-2960 JRNL PMID 9354616 JRNL DOI 10.1021/BI971129X REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.RENATUS,R.A.ENGH,M.T.STUBBS,R.HUBER,S.FISCHER,U.KOHNERT, REMARK 1 AUTH 2 W.BODE REMARK 1 TITL LYSINE 156 PROMOTES THE ANOMALOUS PROENZYME ACTIVITY OF TPA: REMARK 1 TITL 2 X-RAY CRYSTAL STRUCTURE OF SINGLE-CHAIN HUMAN TPA REMARK 1 REF EMBO J. V. 16 4797 1997 REMARK 1 REFN ISSN 0261-4189 REMARK 1 REFERENCE 2 REMARK 1 AUTH W.BODE,M.RENATUS REMARK 1 TITL TISSUE-TYPE PLASMINOGEN ACTIVATOR: VARIANTS AND REMARK 1 TITL 2 CRYSTAL/SOLUTION STRUCTURES DEMARCATE STRUCTURAL REMARK 1 TITL 3 DETERMINANTS OF FUNCTION REMARK 1 REF CURR.OPIN.STRUCT.BIOL. V. 7 865 1997 REMARK 1 REFN ISSN 0959-440X REMARK 1 REFERENCE 3 REMARK 1 AUTH D.LAMBA,M.BAUER,R.HUBER,S.FISCHER,R.RUDOLPH,U.KOHNERT,W.BODE REMARK 1 TITL THE 2.3 A CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF REMARK 1 TITL 2 RECOMBINANT TWO-CHAIN HUMAN TISSUE-TYPE PLASMINOGEN REMARK 1 TITL 3 ACTIVATOR REMARK 1 REF J.MOL.BIOL. V. 258 117 1996 REMARK 1 REFN ISSN 0022-2836 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.851 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 7.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 100000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.1000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.2 REMARK 3 NUMBER OF REFLECTIONS : 8624 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.00 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 835 REMARK 3 BIN R VALUE (WORKING SET) : 0.3489 REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2083 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 25 REMARK 3 SOLVENT ATOMS : 33 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 65.48 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.673 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.93 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.302 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 3.657 ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : 5.967 ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : 5.003 ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : 7.457 ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PARHCSDX.PRO REMARK 3 PARAMETER FILE 2 : PARAM19.SOL REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PRO REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1A5I COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000170417. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-OCT-96 REMARK 200 TEMPERATURE (KELVIN) : 290 REMARK 200 PH : 9.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE(002) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM, ROTAVATA REMARK 200 DATA SCALING SOFTWARE : CCP4 (ROTAVATA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9582 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 200 DATA REDUNDANCY : 2.300 REMARK 200 R MERGE (I) : 0.09200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 3.5100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.9 REMARK 200 DATA REDUNDANCY IN SHELL : 2.40 REMARK 200 R MERGE FOR SHELL (I) : 0.40500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR 3.851 REMARK 200 STARTING MODEL: PDB ENTRY 1RTF REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.66 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.58 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 9.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.06333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 90.12667 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 90.12667 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 45.06333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 ARG A 37B REMARK 475 SER A 37C REMARK 475 ASP A 110A REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLU A 8 CG CD OE1 OE2 REMARK 480 GLN A 60 CG CD OE1 NE2 REMARK 480 GLU A 60A CB CG CD OE1 OE2 REMARK 480 LEU A 60D CG CD1 CD2 REMARK 480 GLU A 78 CG CD OE1 OE2 REMARK 480 ASN A 178 CG OD1 ND2 REMARK 480 TYR A 186F CD2 CE1 CZ OH REMARK 480 MET A 202 SD CE REMARK 480 HIS A 243 CB CG ND1 CD2 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 4 147.18 -171.17 REMARK 500 HIS A 27 61.87 -151.04 REMARK 500 ASN A 37 16.13 -65.95 REMARK 500 ARG A 37A -169.45 84.79 REMARK 500 ARG A 37B -81.33 64.97 REMARK 500 SER A 37C -165.62 166.85 REMARK 500 SER A 37D 66.74 78.11 REMARK 500 CYS A 42 -174.97 -170.21 REMARK 500 SER A 49 -32.32 -34.72 REMARK 500 PHE A 59 74.41 -105.77 REMARK 500 GLN A 60 -70.52 -75.30 REMARK 500 SER A 60B 87.84 -51.54 REMARK 500 PRO A 61 -36.55 -31.92 REMARK 500 HIS A 91 109.47 -44.15 REMARK 500 PRO A 110C 0.90 -65.26 REMARK 500 CYS A 111 -86.37 -77.68 REMARK 500 CYS A 136 -169.40 -128.77 REMARK 500 CYS A 168 75.99 -106.49 REMARK 500 LEU A 171 33.98 -93.09 REMARK 500 ASN A 173 15.72 53.85 REMARK 500 GLU A 186D 148.86 -36.56 REMARK 500 ILE A 186E -60.92 -17.58 REMARK 500 CYS A 191 -167.70 -129.42 REMARK 500 SER A 214 -71.03 -106.74 REMARK 500 ASP A 240 -81.41 -70.26 REMARK 500 ASN A 241 -19.51 -41.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 THE UNBOUND FORM OF THE INHIBITOR IS GLU-GLY-ARG- REMARK 600 CHLOROMETHYLKETONE. UPON REACTION WITH PROTEIN IT FORMS TWO REMARK 600 COVALENT BONDS: 1) A COVALENT BOND TO SER 195 FORMING A HEMIKETAL REMARK 600 AR7 AND 2) A COVALENT BOND TO NE2 OF HIS 57 REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: L-ALPHA-GLUTAMYL-N-{(1S)-4-{[AMINO(IMINIO)METHYL] REMARK 630 AMINO}-1-[(1S)-2-CHLORO-1-HYDROXYETHYL]BUTYL}GLYCINAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 0GJ A 245 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: GLU GLY AR7 0QE REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0GJ A 245 REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE PROTEIN IS A DELETION MUTANT OF FULL-LENGTH DSPAALPHA1 (P98119) REMARK 999 CONSISTING OF A SIGNAL PEPTIDE (THREE RESIDUES) AND THE CATALYTIC REMARK 999 DOMAIN OF FULL LENGTH-DSPAALPHA1. THE FINGER-, EGF- AND KRINGEL- REMARK 999 DOMAIN ARE MISSING. IT IS THEREFORE ALSO CALLED (DELTAFEK) REMARK 999 DSPAALPHA1. THE RESIDUE NUMBERING GIVEN WITH THE COORDINATE SET HAS REMARK 999 BEEN DERIVED FROM THE TOPOLOGY EQUIVALENCE TO CHYMOTRYPSINOGEN (SEE REMARK 999 REFERENCE 1). DBREF 1A5I A 1 244 UNP P98119 URT1_DESRO 213 477 SEQRES 1 A 265 THR CYS GLY LEU ARG LYS TYR LYS GLU PRO GLN LEU HIS SEQRES 2 A 265 SER THR GLY GLY LEU PHE THR ASP ILE THR SER HIS PRO SEQRES 3 A 265 TRP GLN ALA ALA ILE PHE ALA GLN ASN ARG ARG SER SER SEQRES 4 A 265 GLY GLU ARG PHE LEU CYS GLY GLY ILE LEU ILE SER SER SEQRES 5 A 265 CYS TRP VAL LEU THR ALA ALA HIS CYS PHE GLN GLU SER SEQRES 6 A 265 TYR LEU PRO ASP GLN LEU LYS VAL VAL LEU GLY ARG THR SEQRES 7 A 265 TYR ARG VAL LYS PRO GLY GLU GLU GLU GLN THR PHE LYS SEQRES 8 A 265 VAL LYS LYS TYR ILE VAL HIS LYS GLU PHE ASP ASP ASP SEQRES 9 A 265 THR TYR ASN ASN ASP ILE ALA LEU LEU GLN LEU LYS SER SEQRES 10 A 265 ASP SER PRO GLN CYS ALA GLN GLU SER ASP SER VAL ARG SEQRES 11 A 265 ALA ILE CYS LEU PRO GLU ALA ASN LEU GLN LEU PRO ASP SEQRES 12 A 265 TRP THR GLU CYS GLU LEU SER GLY TYR GLY LYS HIS LYS SEQRES 13 A 265 SER SER SER PRO PHE TYR SER GLU GLN LEU LYS GLU GLY SEQRES 14 A 265 HIS VAL ARG LEU TYR PRO SER SER ARG CYS ALA PRO LYS SEQRES 15 A 265 PHE LEU PHE ASN LYS THR VAL THR ASN ASN MET LEU CYS SEQRES 16 A 265 ALA GLY ASP THR ARG SER GLY GLU ILE TYR PRO ASN VAL SEQRES 17 A 265 HIS ASP ALA CYS GLN GLY ASP SER GLY GLY PRO LEU VAL SEQRES 18 A 265 CYS MET ASN ASP ASN HIS MET THR LEU LEU GLY ILE ILE SEQRES 19 A 265 SER TRP GLY VAL GLY CYS GLY GLU LYS ASP VAL PRO GLY SEQRES 20 A 265 VAL TYR THR LYS VAL THR ASN TYR LEU GLY TRP ILE ARG SEQRES 21 A 265 ASP ASN MET HIS LEU HET 0GJ A 245 25 HETNAM 0GJ L-ALPHA-GLUTAMYL-N-{(1S)-4-{[AMINO(IMINIO) HETNAM 2 0GJ METHYL]AMINO}-1-[(1S)-2-CHLORO-1- HETNAM 3 0GJ HYDROXYETHYL]BUTYL}GLYCINAMIDE FORMUL 2 0GJ C14 H28 CL N6 O5 1+ FORMUL 3 HOH *33(H2 O) HELIX 1 1 ILE A 24 HIS A 27 5 4 HELIX 2 2 ALA A 56 CYS A 58 5 3 HELIX 3 3 SER A 165 ARG A 167 5 3 HELIX 4 4 VAL A 231 ASN A 241 5 11 SHEET 1 A 7 ALA A 31 PHE A 34 0 SHEET 2 A 7 LYS A 65 LEU A 68 -1 N VAL A 67 O ALA A 32 SHEET 3 A 7 GLN A 81 VAL A 90 -1 N PHE A 83 O VAL A 66 SHEET 4 A 7 ALA A 104 LYS A 109 -1 N LYS A 109 O LYS A 84 SHEET 5 A 7 TRP A 51 THR A 54 -1 N THR A 54 O ALA A 104 SHEET 6 A 7 ARG A 39 SER A 48 -1 N SER A 48 O TRP A 51 SHEET 7 A 7 GLN A 30 ALA A 35 -1 N ALA A 35 O ARG A 39 SHEET 1 B 2 GLU A 135 GLY A 140 0 SHEET 2 B 2 LYS A 156 ARG A 161 -1 N VAL A 160 O CYS A 136 SHEET 1 C 4 MET A 180 ALA A 183 0 SHEET 2 C 4 GLY A 226 LYS A 230 -1 N TYR A 228 O LEU A 181 SHEET 3 C 4 HIS A 206 TRP A 215 -1 N TRP A 215 O VAL A 227 SHEET 4 C 4 PRO A 198 ASN A 203 -1 N ASN A 203 O HIS A 206 SSBOND 1 CYS A 1 CYS A 122 1555 1555 2.02 SSBOND 2 CYS A 42 CYS A 58 1555 1555 2.02 SSBOND 3 CYS A 50 CYS A 111 1555 1555 2.03 SSBOND 4 CYS A 136 CYS A 201 1555 1555 2.04 SSBOND 5 CYS A 168 CYS A 182 1555 1555 2.02 SSBOND 6 CYS A 191 CYS A 220 1555 1555 2.03 LINK NE2 HIS A 57 C3 0GJ A 245 1555 1555 1.49 LINK OG SER A 195 C2 0GJ A 245 1555 1555 1.40 SITE 1 AC1 14 HIS A 57 TYR A 99 LYS A 174 ASP A 189 SITE 2 AC1 14 ALA A 190 CYS A 191 GLN A 192 GLY A 193 SITE 3 AC1 14 ASP A 194 SER A 195 SER A 214 TRP A 215 SITE 4 AC1 14 GLY A 216 GLY A 219 CRYST1 73.860 73.860 135.190 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013539 0.007817 0.000000 0.00000 SCALE2 0.000000 0.015634 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007397 0.00000